Gaithersburg biotechnology company Novavax announced Monday that it has reached an agreement in principle to give Canada up to 76 million doses of Novavax’s COVID-19 vaccine. In a statement the company said the vaccine is in multiple Phase 2 clinical trials right now. Novavax expects to finalize an agreement that would begin supplying the doses […]
canadians
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia